Journal of dermatological science, 2017-10, Vol.88 (1), p.36-45
2017
Details
- Autor(en) / Beteiligte
- Titel
- The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: a Phase 3, randomized, double-blind, placebo-controlled study
- Ist Teil von
- Journal of dermatological science, 2017-10, Vol.88 (1), p.36-45
- Ort / Verlag
- Netherlands: Elsevier B.V
- Erscheinungsjahr
- 2017
- Link zum Volltext
- Quelle
- Alma/SFX Local Collection
- Beschreibungen/Notizen
- Highlights • Tofacitinib is an oral Janus kinase inhibitor. • Tofacitinib showed superior efficacy vs placebo in Asian patients with psoriasis. • No unexpected safety findings were observed in Asian patients vs global studies.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0923-1811eISSN: 1873-569XDOI: 10.1016/j.jdermsci.2017.05.004Titel-ID: cdi_proquest_miscellaneous_1904231032
- Format
- –
- Schlagworte
- Asia, Dermatology, Efficacy, Janus kinase inhibitor, Plaque psoriasis, Safety, Tofacitinib